High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients

Tumor Biology - United States
doi 10.1177/1010428317720212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Increased CX3CL1 mRNA Expression Level Is a Positive Prognostic Factor in Patients With Lung Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2019English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Prognostic Significance of CD44 Expression in Adenocarcinoma of the Lung

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1996English

Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients With Lung Adenocarcinoma

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Prognostic Significance of IMMT Expression in Surgically‐resected Lung Adenocarcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Overexpression of PSAT1 Gene Is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients With IDH1 Mutations and Chromosome 1p19q Codeletion

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy